Search

Your search keyword '"Crespo-Leiro, M."' showing total 301 results

Search Constraints

Start Over You searched for: Author "Crespo-Leiro, M." Remove constraint Author: "Crespo-Leiro, M."
301 results on '"Crespo-Leiro, M."'

Search Results

1. Updates from the International Consortium on Primary Graft Dysfunction: An Interim Report and Important Themes

2. Impact of the 2018 UNOS Allocation Change on Severe Primary Graft Dysfunction: A Report from the International Consortium on PGD

3. Validation of a Machine Learning Primary Graft Dysfunction Risk Score in a Contemporary Heart Transplant Cohort: An Analysis of the International Consortium on PGD

4. Transitions Between Molecular Rejection Classes in Heart Endomyocardial Biopsies

5. Genome-Wide Molecular Analysis of Heart Transplant Endomyocardial Biopsies Separately Analyzing Rejection and Parenchymal Injury

6. Mitigating Risk by Using the Primary Graft Dysfunction-Artificial Intelligence (PGD-AI) Calculator in a Contemporary Toronto Cohort: An Analysis from The International Consortium on PGD

7. Comparative Regional Analysis of Severe Primary Graft Dysfunction: Insights from Tthe International Consortium on PGD

8. Elevated lipoprotein a level in heart transplant patients is associated with cardiac allograft vasculopathy

10. Role of NTproBNP and donor-derived cell-free DNA in the diagnosis of acute rejection in heart transplant recipients: a prospective study

11. Donor-derived cell-free DNA as a new biomarker for acute rejection in heart transplant recipients: results from the freedna car study

12. Donor-derived cell-free DNA kinetics in the first year post-transplant in patients without acute cellular rejection

13. Validation of miR-181A-5p as a biomarker of acute rejection after heart transplantation. Multicenter study

14. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

15. Sex‐ and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry

16. (1006) Donor-Derived Cell-Free DNA as a Potential Biomarker for Acute Cellular Rejection Surveillance (FreeDNA-CAR Study)

17. (585) Impact of the SarsCov2 Booster Dose on Clinical Events in Heart Transplant Patients in Galicia. INMU TC Study

18. Incidence and Predictors of Vasoplegia after Heart Transplantation: Results from the International PGD Consortium

19. Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

20. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

21. Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: Calcineurin-inhibitors conversion or minimization?

23. Specialized proresolving mediators protect against experimental autoimmune myocarditis by modulating Ca2+ handling and NRF2 activation

24. Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry

25. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world

28. Serum potassium dynamics during acute heart failure hospitalization

31. (770) - Comparative Regional Analysis of Severe Primary Graft Dysfunction: Insights from Tthe International Consortium on PGD

32. (768) - Mitigating Risk by Using the Primary Graft Dysfunction-Artificial Intelligence (PGD-AI) Calculator in a Contemporary Toronto Cohort: An Analysis from The International Consortium on PGD

33. (326) - Impact of the 2018 UNOS Allocation Change on Severe Primary Graft Dysfunction: A Report from the International Consortium on PGD

34. (285) - Sex Based Differences in Severe Primary Graft Dysfunction: An Analysis from the International Consortium on PGD

35. (124) - Validation of a Machine Learning Primary Graft Dysfunction Risk Score in a Contemporary Heart Transplant Cohort: An Analysis of the International Consortium on PGD

36. (122) - Updates from the International Consortium on Primary Graft Dysfunction: An Interim Report and Important Themes

40. Specialized pro-resolving mediators prevents cardiac dysfunction by modulating Ca2+ handling and NRF2 axis

43. Specialized pro-resolving mediators prevents cardiac dysfunction by modulating Ca2+ handling and NRF2 axis

44. New Molecular Classification of Rejection in Heart Transplant Biopsies Reveals Relatively Little Three Year Graft Loss in Antibody-Mediated Rejection

45. The falling incidence of hematologic cancer after heart transplantation

47. Perioperative Pectoralis Muscle Mass and Attenuation Estimated by Computed Tomography are Not Predictors for Mortality after Heart Transplantation

48. Improvement of Adherence to Drug Therapy Using a Weekly Multidose Pillbox in Heart Transplant Patients. A Prospective Single-Center Study

49. New Molecular Classification of Rejection in Heart Transplant Biopsies Reveals Relatively Little Three Year Graft Loss in Antibody-Mediated Rejection

50. Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure

Catalog

Books, media, physical & digital resources